实用肿瘤学杂志 ›› 2009, Vol. 23 ›› Issue (1): 1-3.

• 论著 •    下一篇

动脉化疗配合手术治疗浸润性膀胱癌远期疗效的临床观察

李长福, 陈永胜, 杨巍   

  1. 哈尔滨医科大学附属肿瘤医院泌尿外科(哈尔滨 150081)
  • 收稿日期:2008-10-14 出版日期:2009-01-20 发布日期:2012-02-21
  • 作者简介:李长福, 男, (1965-), 博士, 从事泌尿系肿瘤的诊断与治疗研究
  • 基金资助:
    黑龙江省自然科学基金资助项目(D00-32)

Long-term efficacious observation on the arterial chemotherapy and operation for invasive bladder cancer

LI Changfu, CHEN Yongsheng, YANG Wei   

  1. Department of Urology, The Affiliated Tumour Hospital of Harbin Medical University, Harbin 150081
  • Received:2008-10-14 Online:2009-01-20 Published:2012-02-21

摘要: 目的探讨动脉化疗配合手术治疗浸润性膀胱癌远期疗效。方法 将行膀胱部分切除术的63例浸润性膀胱癌患者分成2组, 动脉化疗组30例, 术前、术后2周行动脉化疗, 对照组33例, 患者不同意动脉化疗。对两组63例病人术后进行5年随访, 观察患者的术后复发率、中位生存时间, 比较其生存率, 同时还观察动脉化疗组动脉化疗期间病灶的变化以及药物的毒副反应。结果 动脉化疗组中位生存时间为58个月, 高于对照组(32个月), 且生存曲线也高于对照组, 经Log-Rank检验, P<0.01, 且动脉化疗期间, 病灶总缓解率为46.67%, 药物毒副反应也仅在0-Ⅰ度之间。结论 行膀胱部分切除术的浸润性膀胱癌病人术前术后配合动脉化疗能降低复发率, 提高生存率, 术前可以使部分病灶缩小, 且药物毒副反应患者能够耐受, 值得临床推广。

关键词: 动脉化疗, 手术, 浸润性膀胱癌, 疗效

Abstract: Objective To investigate long-term efficacy on the arterial chemotherapy and operation for invasive bladder cancer.Methods The 63 patients with invasive bladder cancer were divided into two groups were treated by partial cystectomy.30 patients among the total ones were arterial chemotherapy, they were treated with arterial chemotherapy on preoperative two weeks and postoperative two weeks.The other 33 patients in control group received no any arterial chemotherapy.All 63 cases were followed up five years after operation, in order to observe postoperative recurrence, the middle live time and compare survival rate between the two groups.Moreover, we observed the focus changes during the period of arterial chemotherapy and toxical-side effects about these drugs.Results The middle live time of arterial chemotherapy patients were 58 months, much longer than that of control group, the later was only 32 months.The survival rate in arterial chemotherapy group was higher than that in control group.Log-rank test was proved P<0.01, which indicated significantly in statistics.We also found that the remission rate of the focus was 46.67 percent, the toxical-side effects were only 0-Ⅰdegree.Conclusions The recurrence rate could be obviously depressed and the survival rate could be increased in patients treated by partial cystectomy with invasive bladder cancer through preoperative and postoperative arterial chemotherapy, the part focus of infection could be relieved before operation.Furthermore, all cases could tolerate the toxical-side effects of the drugs.Therefore, arterial chemotherapy and operation for invasive bladder cancer is a potential way and deserves to spread clinically, especially with invasive bladder cancer.

Key words: Arterial Chemotherapy, Operation, Invasive Bladder Cancer, Curative Effect.

中图分类号: